SIGA · SIGA Technologies Inc

-

Please sign in to comment on SIGA

1 Comment

Admin

4 years, 1 month ago

SIGA Technologies, Inc is currently in a long term downtrend where the price is trading 14.2% below its 200 day moving average.

From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.4.

SIGA Technologies, Inc's total revenue rose by 784.8% to $38M since the same quarter in the previous year.

Its net income has increased by 547.8% to $20M since the same quarter in the previous year.

Finally, its free cash flow grew by 422.1% to $46M since the same quarter in the previous year.

Based on the above factors, SIGA Technologies, Inc gets an overall score of 4/5.

ISIN	US8269171067
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Exchange	NASDAQ
CurrencyCode	USD

Beta	0.93
Dividend Yield	0.0%
Market Cap	404M
PE Ratio	6.9
Target Price	17.53

ABOUT

SIGA Technologies Inc

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. Its lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

SIGA · SIGA Technologies Inc

-

SIGA Technologies Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest SIGA Technologies Inc using a moving average strategy